Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01078519
Other study ID # NCT00992524
Secondary ID
Status Completed
Phase Phase 3
First received February 25, 2010
Last updated July 14, 2010
Start date January 2010
Est. completion date June 2010

Study information

Verified date December 2007
Source Instituto Materno Infantil Prof. Fernando Figueira
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

Maternal intra-partum fever commonly complicates the process of labour. Its occurrence is often regarded as being synonymous with the presence of chorioamnionitis. This inevitably results in the administration of antibiotics to the affected mother. Review of the literature however suggests that this approach is not always appropriate. Non-infective causes of this condition that are often overlooked include the use of epidural analgesia for pain relief, normal thermal physiological changes in women not using any form of analgesia and delivery in an overheated room. Women with certain risk factors such as nulliparity and a long latent phase of labour are also more prone to developing maternal intra-partum fever. Irrespective of its aetiology, maternal intra-partum fever carries risks both for the mother and her unborn child. Putting more thought into the care of these patients will go a long way in reducing the maternal and neonatal morbidity associated with this complication.The combined spinal-epidural (CSE) technique has been introduced in an attempt to reduce these adverse effects. CSE is believed to during labour provide more rapid onset of analgesia than epidural analgesia, The incidence of fever is significantly lower with CSE technique.


Description:

The objective this study is determine the fever maternal incidence with CSE technique for labor analgesia.

METHODS: a randomized open clinical trial will be conducted involving Seventy healthy, term, nulliparous women in spontaneous labor were assigned to either CSE technique or non pharmacologic analgesia for labor.these patients will be randomly assigned to receive or not CSE technique for labor analgesia. Outcomes analysis wiil include maternal fever, pain intensity measured by visual analog scale, labor duration, c-section and instrumental delivery. statical analysis will performed using Mann-Whitney and Fisher" exact test 5% level of significance.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- singleton pregnancies

- babies were presenting head first

- were expecting a vaginal delivery single fetal

- gestational age up to 37 weeks

- cervix length between 3-6 cm

Exclusion Criteria:

- Maternal fever before randomization

- Antibiotics before randomization

- haemostatic disorders during pregnancy

- severe preeclâmpsia-eclampsia

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Combined epidural and spinal anesthesia
Obstetrics patients will relieve spinal anesthesia with local anesthesics and opioids associated with epidural anesthesia with local anesthetics in low concentrations with opioids

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Instituto Materno Infantil Prof. Fernando Figueira

Outcome

Type Measure Description Time frame Safety issue
Primary Fever frequency We will measure the temperature each hour each hour Yes
Secondary Incidence of c-section and instrumental delivery Will measure the instrumental delivery when the CSA technique is used within the delivery Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04397380 - COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study
Completed NCT00438269 - Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection Phase 2
Recruiting NCT04652258 - Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated With Dabrafenib/ Trametinib +/- Immunotherapy Phase 2